CTVA analyst estimates
Corteva (CTVA) analyst ratings, the average price target and its range, and every firm's latest call.
CTVA analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 12, 2026 | UBS | Corteva price target lowered to $15 from $90 at UBS | $15.00 |
| Oct 8, 2026 | Goldman Sachs | Corteva Inc. (CTVA) PT Lowered to $20 at Goldman Sachs | $20.00 |
| Oct 7, 2026 | KeyBanc | KeyBanc Upgrades Corteva Inc. (CTVA) to Overweight | $17.00 |
| Oct 7, 2026 | RBC Capital | Corteva Inc. (CTVA) PT Lowered to $17 at RBC Capital | $17.00 |
| Oct 5, 2026 | Oppenheimer | Corteva Inc. (CTVA) PT Lowered to $17 at Oppenheimer | $17.00 |
| Oct 5, 2026 | New Street | Oppenheimer lowers Corteva price target to $17 from $95 after spinoff | $17.00 |
| Oct 2, 2026 | Morgan Stanley | Corteva price target adjusted to $18 at Morgan Stanley after Vylor spinoff | $18.00 |
| Oct 2, 2026 | BMO Capital | Corteva price target adjusted to $15 at BMO Capital after Vylor spinoff | $15.00 |
| Sep 24, 2026 | Oppenheimer | Oppenheimer Reiterates Outperform Rating on Corteva Inc. (CTVA) | $95.00 |
| Sep 16, 2026 | UBS | Corteva price target raised to $90 from $85 at UBS | $90.00 |
| Sep 16, 2026 | New Street | Corteva price target lowered to $95 from $100 at BMO Capital | $95.00 |
| Sep 16, 2026 | BMO Capital | Corteva Inc. (CTVA) PT Lowered to $95 at BMO Capital | $95.00 |
| Aug 3, 2026 | BMO Capital | Corteva price target raised to $100 from $95 at BMO Capital | $100.00 |
| Aug 3, 2026 | Deutsche Bank | Corteva price target raised to $101 from $100 at Deutsche Bank | $101.00 |
| Jul 21, 2026 | RBC Capital | Corteva price target raised to $103 from $97 at RBC Capital | $103.00 |
- 13 firms rate CTVA: 11 buy, 2 hold, 0 sell.
- The average price target is $26.33 from 9 analysts, from $15.00 to $101.00.
Updated 2026-11-02 17:52 UTC